BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 18, 2020
View Archived Issues
How CDK comes unglued
Read More
HRAS-driven translation helps skin prevent tumors
Read More
Phase I study of BAY-1436032 in advanced AML patients with mutant IDH1
Read More
Preliminary phase I results suggest neihulizumab safety and efficacy in sr-aGvHD
Read More
Hyundai Pharmaceutical presents phase I data for GPR40 agonist HD-6277 in type 2 diabetes
Read More
Stayble Therapeutics initiates phase IIb study of STA-363
Read More
Positive data presented from FASCINATE-1 phase II study of ASC-40
Read More
Dare Bioscience initiates pivotal phase III study of DARE-BV1 in bacterial vaginosis
Read More
Encouraging interim data presented from phase II/III study of IFX-1 in severe COVID-19
Read More
Safety run-in results from phase I/II study of VXM-01 plus avelumab in progressive glioblastoma
Read More
First clinical results presented for PXS-5505
Read More
Otsuka Pharmaceutical presents new antiseizure compounds
Read More
New MALT1 inhibitors discovered at Takeda
Read More
Novartis describes new PCSK9 inhibitors
Read More
Merck & Co. patents IDO-1 inhibitors
Read More
GlaxoSmithKline and collaborators identify NF-kappaB activators/HIV latency-reversing agents
Read More
Xoc Pharmaceuticals presents phase I data for XC101-D13H in preventing migraine
Read More
Aevi begins phase II study of CERC-002 in patients with COVID-19 pneumonia and acute lung injury
Read More
Preclinical and phase I studies demonstrate KER-050 potential for treating hematopoiesis disorders
Read More
Sanofi begins phase III trials of SAR-442168 in MS
Read More
ViralClear enrolls patients with advanced COVID-19 in phase II trial of merimepodib with remdesivir
Read More
New phase I trial studies TQB-3474 in advanced malignant tumors
Read More
New targets and "molecular beacon" give new insights into senescence
Read More
Phase II trial explores axatilimab in patients with respiratory involvement secondary to COVID-19
Read More